Novo Nordisk
NVO
#19
Rank
C$671.38 B
Marketcap
$147.90
Share price
-1.49%
Change (1 day)
8.83%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Cash on Hand

Cash on Hand as of September 2024 : C$15.75 Billion

According to Novo Nordisk's latest financial reports the company has C$15.75 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Novo Nordisk - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$5.93 B28.91%
2022-12-31C$4.60 B35.78%
2021-12-31C$3.39 B26.18%
2020-12-31C$2.68 B-11.27%
2019-12-31C$3.03 B-7.15%
2018-12-31C$3.26 B-14.58%
2017-12-31C$3.82 B-2.98%
2016-12-31C$3.93 B-5.33%
2015-12-31C$4.16 B38%
2014-12-31C$3.01 B5.72%
2013-12-31C$2.85 B0.42%
2012-12-31C$2.83 B-8.44%
2011-12-31C$3.10 B8.31%
2010-12-31C$2.86 B10.14%
2009-12-31C$2.59 B11.79%
2008-12-31C$2.32 B61.3%
2007-12-31C$1.44 B36.86%
2006-12-31C$1.05 B13.88%
2005-12-31C$0.92 B6.04%
2004-12-31C$0.87 B28.33%
2003-12-31C$0.67 B71.92%
2002-12-31C$0.39 B-43.39%
2001-12-31C$0.69 B154.22%
2000-12-31C$0.27 B4.18%
1999-12-31C$0.26 B49.83%
1998-12-31C$0.17 B-23.71%
1997-12-31C$0.23 B28.19%
1996-12-31C$0.17 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$13.97 B-11.28%๐Ÿ‡บ๐Ÿ‡ธ USA
C$4.94 B-68.63%๐Ÿ‡บ๐Ÿ‡ธ USA
C$11.36 B-27.84%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.22 B-35.06%๐Ÿ‡ซ๐Ÿ‡ท France